A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is a phase I, single-center, randomized, double-blind, placebo-controlled study of AK0406 as a first-in-human (FIH) trial to evaluate the safety, tolerability and pharmacokinetics (PK) of AK0406 in healthy adult participants.
Epistemonikos ID: 2d1934a66826d043de17c0c54cc792d215d0cb4b
First added on: Feb 26, 2026